{"id":"ultrix-quadri","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"QT interval prolongation"},{"rate":"5-10%","effect":"Bradycardia"},{"rate":"rare","effect":"Torsades de pointes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It combines amiodarone, sotalol, propafenone, and dronedarone to manage irregular heart rhythms. This combination aims to provide a more effective treatment option for patients with atrial fibrillation.","oneSentence":"Ultrix Quadri is a combination of four anti-arrhythmic medications used to treat atrial fibrillation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:37:08.530Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"},{"name":"Atrial fibrillation for rate control"}]},"trialDetails":[{"nctId":"NCT05869201","phase":"PHASE2, PHASE3","title":"Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine","status":"COMPLETED","sponsor":"St. Petersburg Research Institute of Vaccines and Sera","startDate":"2020-10-06","conditions":"Influenza, Influenza, Human, Influenza Viral Infections","enrollment":450},{"nctId":"NCT05232292","phase":"PHASE4","title":"Influenza Vaccination During Coronavirus Disease 2019 Outbreak After Acute Coronary Syndrome and Chronic Heart Failure","status":"UNKNOWN","sponsor":"Samara Regional Cardiology Dispensary","startDate":"2021-10-06","conditions":"Acute Coronary Syndrome, Chronic Heart Failure","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ultrix Quadri","genericName":"Ultrix Quadri","companyName":"Samara Regional Cardiology Dispensary","companyId":"samara-regional-cardiology-dispensary","modality":"Biologic","firstApprovalDate":"","aiSummary":"Ultrix Quadri is a combination of four anti-arrhythmic medications used to treat atrial fibrillation. Used for Atrial fibrillation for stroke prevention, Atrial fibrillation for rate control.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}